Zapping cancer spots: new radiation strategy may extend current Drug's power
NCT ID NCT06260033
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether precise radiation (SBRT) can treat a few growing tumors in patients with ER+ breast cancer that has spread, allowing them to continue their current medication longer. About 18 adults with limited disease progression will receive SBRT and be monitored. The goal is to see if this approach delays the need to switch to a new drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE IV BREAST CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
-
City of Hope at Irvine Lennar
RECRUITINGIrvine, California, 92618, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital therapy aims to tame the fear that haunts cancer survivors
- Engineered immune cells join chemo and antibody to attack Hard-to-Treat breast cancer
- Could a gentler chemo work for older breast cancer patients?
- Genetic clues in blood and tumors could personalize breast cancer care
- Can couples coping together ease the burden of advanced cancer?
- Blood test could track breast cancer in real time